Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 35

Observing how EPA is metabolized considering genetics and sex

Official title: Determining Contribution of Sex and Genetics to DHA Synthesis Rates Over 12 Weeks of EPA Supplementation in Healthy Individuals

Run by University of Toronto · NCT06975241 · Data updated 2026-11-12

This study is testing how well healthy adults convert an omega-3 supplement into another important fatty acid, while looking at how genetics and sex might affect this process.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment64 (estimated)
SponsorUniversity of Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJuly 29, 2025
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedFebruary 27, 2026
Trial IDNCT06975241 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults with a BMI between 18.5 and 30 kg/m² who do not consume high amounts of omega-3 fatty acids.

Probably not a fit

Patients with chronic diseases, those on certain medications, or individuals with high omega-3 intake may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study aims to investigate the metabolism of eicosapentaenoic acid (EPA) in healthy adults, focusing on how quickly EPA is converted to docosahexaenoic acid (DHA) and whether this conversion is influenced by biological sex and specific genetic factors. Participants will take EPA supplements for 12 weeks and provide blood samples to measure the conversion rates and levels of DHA and other metabolites. The study seeks to understand the dynamics of omega-3 fatty acid metabolism in relation to genetic and sex differences.

Why it matters

Potential benefit: If successful, this study could provide insights into personalized nutrition strategies for optimizing omega-3 fatty acid metabolism.

How similar studies have gone: While studies on omega-3 metabolism exist, this specific focus on genetic and sex differences in EPA metabolism is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI between 18.5- 30 kg/m2
* healthy

Exclusion Criteria:

* Consumption of fish/seafood or EPA/DHA-enriched foods currently or within the previous 6 months
* Consumption of any supplements containing ALA/EPA/DHA currently or within the previous 6 months
* Allergies to any component of the study supplement (fish, gelatin etc.)
* BMI \<18.5 kg/m² or \>30 kg/m²
* Women who are pregnant, breastfeeding or planning on becoming pregnant
* Diagnosis with chronic or communicable diseases
* Prescription of chronic pharmacological medications (except for oral contraceptives)
* High blood pressure (systolic or diastolic blood pressure above 130 or 80mmHg, respectively)
* Hypertriglyceridemia (serum \> or = 1.69 mmol/l)
* Hypercholesterolemia (serum LDL-C \> or =5 mmol/l)
* Anticipated changes in lifestyle within the next 4 months
* Smoking
* Heavy alcohol use (\>3 drinks/day)
* Major surgery in the last six months

Where it's running

  • Clinical Nutrition and Risk Factor Modification Centre
    Toronto, Ontario, Canada
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.